Press release
Stores Pull Bottles From Shelves After Acetaminophen Recall Announcement
Eleven million bottles of generic-brand acetaminophen made by Michigan-based drug manufacturer the Perrigo Company were recalled on Nov. 9. The U.S. Food and Drug Administration (FDA) informed the public to the recall, which is for 383 lots of 500-milligram acetaminophen caplets that were manufactured and distributed under generic or store brands sold at retailers like Walgreens, CVS and Wal-Mart.Bottles included in the acetaminophen recall contained small metal bits and fragments — an estimated 11 million bottles are affected. The FDA noted that the chance of the acetaminophen causing serious health consequences is small, though consumers should still take caution — anyone who swallows an affected pill could suffer stomach discomfort and cuts to the mouth and throat. If you have ingested one of the caplets included in the acetaminophen recall and believe you are in danger, do not hesitate to call a doctor. Those consumers who are wondering whether they are possession of the recalled acetaminophen can find out by locating the batch number printed on the container label and checking at the FDA’s list of acetaminophen recall at www.fda.gov/oc/po/firmrecalls/perrigo/perrigobatchlist.html. When the FDA announced the recall on Nov. 9, there were no immediate reports of illness or injuries.
Most commonly known as the drug in products sold under the brand name Tylenol, acetaminophen is taken to treat minor aches and pains, including headaches, backaches and arthritis pain. The recall does not include any Tylenol products. Despite the recall, the FDA stresses that the public should not worry about there being an acetaminophen shortage. The nonprescription drug will still be available at retailers nationwide.
Consumers who believe they are in possession of the recalled acetaminophen or those who have ingested the caplets should also contact the Perrigo Company at 877-546-0504.
Christian Hill
1445 N. Loop West Suite 900
Houston, Texas 77008
(713) 862-9990
Toll free (800) 529-9399
www.christianhill.net
Houston Personal Injury lawyer Christian Hill has successfully handled thousands of personal injury cases since 1991. Christian has recovered more than $100 Million in medical and income benefits for his personal injury clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stores Pull Bottles From Shelves After Acetaminophen Recall Announcement here
News-ID: 13032 • Views: …
More Releases for FDA
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes…
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming
CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility…
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug…
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30).
Announcing New Design Control Training Courses
Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a…
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation.
GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet…
FDA online training
Description:
Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding…
